In a recent paper published in Cell Research,an association between expression of mitochondrial aldehyde dehydrogenase (ALDH2),a mitochondrial chaperon expressed in the brain,and the prevalence of stroke is revealed.This finding indicates that ALDH2 may serve as a potential endogenous neuroprotective target and a promising therapeutic strategy for the management of stroke.